Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy

被引:84
作者
Chernykh, V. V. [1 ]
Varvarinsky, E. V. [1 ]
Smirnov, E. V. [1 ]
Chernykh, D. V. [1 ]
Trunov, Alexander N. [1 ,2 ]
机构
[1] Minist Hlth Russian Federat, SN Fyodorov Fed State Inst, Novosibirsk Branch, Vitreoretinal Dept, Novosibirsk, Russia
[2] Russian Acad Med Sci, Res Ctr Clin & Expt Med, Siberian Branch, Dept Immunol, Novosibirsk, Russia
关键词
Cytokines; diabetic retinopathy; pigment epithelium-derived factor; vascular endothelial growth factor; ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; ANGIOGENESIS; PROTEIN-1; CYTOKINES; CELLS;
D O I
10.4103/0301-4738.151464
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The purpose was to measure the concentrations of various cytokines and growth factors (including vascular endothelial growth factor [VEGF] and pigment epithelium-derived factor [PEDF]) in the vitreous of patients with proliferative diabetic retinopathy (PDR) and to investigate interaction between inflammatory and proliferative factors in the genesis of PDR. Materials and Methods: Vitreous samples from 32 eyes with PDR and 25 eyes without diabetes mellitus and signs of DR (control) were collected. Vitreous concentrations of VEGF, PEDF, monocyte chemotactic protein-1 (MCP-1), interleukin-4 (IL-4), IL-6, IL-8, IL-10, IL-17A, and secretory immunoglobulin A (sIgA) were simultaneously measured using enzyme-linked immunoassay. Results: Vitreous levels of VEGF, PEDF, IL-17A, IL-6, IL-8, IL-4, and sIgA were significantly (P < 0.05) higher in eyes with PDR compared to control. The concentration of VEGF was more than 17-times higher than in control, and the concentration of PEDF was not changed oppositely and was also higher (1.45-times) compared to control, that may indicate disturbances of compensatory mechanisms in angiogenesis regulation in PDR. Significant (P < 0.05) positive correlations were observed between vitreous concentrations of VEGF and IL-17. (r = 0.45), VEGF and IL-8 (r = 0.48), VEGF and IL-4 (r = 0.51), PEDF and IL-17. (r = 0.48), PEDF and IL-8 (r = 0.59), MCP-1 and PEDF (r = 0.72), MCP-1 and IL-8 (r = 0.45), IL-4 and IL-17. (r = 0.65), IL-4 and IL-8 (r = 0.71), IL-8 and IL-17. (r = 0.59). Conclusions: Significantly raised levels of inflammatory and proliferative factors and numerous positive correlations between them may demonstrate a significant role of activation of vascular proliferation and local inflammation in the pathogenesis of PDR.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 25 条
[1]  
Balashevich LI, 2004, OCULAR MANIFESTATION, P382
[2]   Diabetic retinopathy: The latest in current management [J].
Bhavsar, Abdhish R. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (06) :S71-S79
[3]  
Chernykh VV, 2011, B NOVOSIBIRSK STATE, V9, P164
[4]   Vitreous Vascular Endothelial Growth Factor Concentrations in Proliferative Diabetic Retinopathy versus Proliferative Vitreoretinopathy [J].
Citirik, Mehmet ;
Kabatas, Emrah Utku ;
Batman, Cosar ;
Akin, Kadir Okhan ;
Kabatas, Naciye .
OPHTHALMIC RESEARCH, 2012, 47 (01) :7-12
[5]  
Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO
[6]  
2-F
[7]  
Khodjaev NS, 2011, B NOVOSIBIRSK STATE, V9, P48
[8]   Diabetic Retinopathy Early Diagnosis and Effective Treatment [J].
Kollias, Aris N. ;
Ulbig, Michael W. .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (05) :75-83
[9]   Metabolic memory and diabetic retinopathy: Role of inflammatory mediators in retinal pericytes [J].
Kowluru, Renu A. ;
Zhong, Qing ;
Kanwar, Mamta .
EXPERIMENTAL EYE RESEARCH, 2010, 90 (05) :617-623
[10]  
Libman E S, 2006, Vestn Oftalmol, V122, P35